SOLIRIS: payments to doctors
Payments that named SOLIRIS as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $9.1M
- Providers
- 13,446
- Transactions
- 51,364
- Average per transaction
- $176
The per-transaction average — $176 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 13,446 providers the average total is $673, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| AstraZeneca | $9,050,029 | 100.0% |